Moors & Cabot, Inc. Spectrum Pharmaceuticals Inc Transaction History

Moors & Cabot, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$0.38 - $1.07 $912 - $2,568	2,400 Added 24.0%	12,400 $9,000
Q4 2022 Feb 09, 2023	BUY	$0.32 - $0.52 $3,200 - $5,200	10,000 New	10,000 $3,000
Q3 2022 Nov 07, 2022	BUY	$0.43 - $1.56 $5,332 - $19,344	12,400 New	12,400 $5,000
Q3 2021 Nov 05, 2021	BUY	$2.15 - $3.82 $38,700 - $68,760	18,000 New	18,000 $26,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.